Hepatic soluble epoxide hydrolase A promising target for unveiling the liver-brain axis in Alzheimer's disease

被引:1
|
作者
Inoue, Yasuteru [1 ]
Bamkole, Michael [1 ]
Kanekiyo, Takahisa [1 ]
机构
[1] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA
关键词
PATHOLOGY;
D O I
10.1016/j.neuron.2023.08.019
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Wu and Dong et al.(1) report that hepatic soluble epoxide hydrolase (sEH) manipulation impacts amyloid-beta (A beta) deposits and cognitive impairment in mouse models for Alzheimer's disease (AD), suggesting that hepatic sEH activity is a promising therapeutic target to treat AD.
引用
收藏
页码:2775 / 2777
页数:3
相关论文
共 50 条
  • [1] Modulation of the liver-brain axis by alcohol and its impact on Alzheimer's disease pathology
    Garcia, J.
    Chandrashekar, D. V.
    Steinberg, R. A.
    Chang, R.
    Sanchez, F.
    Khal, E.
    Sumbria, R. K.
    Han, D.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 : 86 - 86
  • [2] Past, Present, and Future of Liver-Brain Axis in Alzheimer's Disease: A Bibliometric Review
    Liu, Xin Lian
    Yeerlan, Jianishaya
    Liu, Zhirong
    Bai, Yang
    Wang, Qin
    Yan, YiRui
    Xu, LuKe
    Jia, Cui
    Zhang, LuShun
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 101 (04) : 1267 - 1280
  • [3] Soluble epoxide hydrolase: a promising therapeutic target for cardiovascular diseases
    Ni, Guo-Hua
    Chen, Jin-Fang
    Chen, Xiao-Ping
    Yang, Tian-Lun
    PHARMAZIE, 2011, 66 (03): : 153 - 157
  • [4] HEPATIC CEREBROSTEROL METABOLISM IN THE 3xTg-AD MOUSE: IMPLICATIONS FOR THE LIVER-BRAIN AXIS IN THE PATHOGENESIS OF ALZHEIMER'S DISEASE
    Bosoi, Cristina R.
    Vandal, Milene
    Tournissac, Marine
    Fanet, Hortense
    Mitchell, Patricia
    Verreault, Melanie
    Trottier, Jocelyn
    Barbier, Olivier
    Marette, Andre
    Calon, Frederic
    HEPATOLOGY, 2019, 70 : 1336A - 1336A
  • [5] Soluble epoxide hydrolase: a next-generation drug target for Alzheimer's disease and related dementias
    Gregory, Andrew
    Tang, Chengyun
    Fan, Fan
    NEURAL REGENERATION RESEARCH, 2025, 20 (09) : 2585 - 2586
  • [6] Unraveling the Role of LRP1 in Alzheimer’s Disease: A Focus on Aβ Clearance and the Liver-Brain Axis
    Wanyue Yang
    Zilin Wei
    Tianhui Wang
    Journal of Molecular Neuroscience, 75 (2)
  • [7] Liver-Brain Axis in Sporadic Alzheimer's Disease: Role of Ten Signature Genes in a Mouse Model
    Jakhmola-Mani, Ruchi
    Islam, Anam
    Katare, Deepshikha Pande
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2021, 20 (09) : 871 - 885
  • [8] Hepatic soluble epoxide hydrolase activity regulates cerebral AD metabolism and the pathogenesis of Alzheimer's disease in mice
    Wu, Yu
    Dong, Jing-Hua
    Dai, Yong-Feng
    Zhu, Min-Zhen
    Wang, Meng-Yao
    Zhang, Yuan
    Pan, Yi-Da
    Yuan, Xin-Rui
    Guo, Zhi-Xin
    Wang, Chen-Xi
    Li, Yuan-Qing
    Zhu, Xin-Hong
    NEURON, 2023, 111 (18) : 2847 - +
  • [9] Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer’s disease
    Hsueh-Te Lee
    Kuan-I Lee
    Chia-Hui Chen
    Tzong-Shyuan Lee
    Journal of Neuroinflammation, 16
  • [10] Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease
    Grinan-Ferre, Christian
    Codony, Sandra
    Pujol, Eugenia
    Yang, Jun
    Leiva, Rosana
    Escolano, Carmen
    Puigoriol-Illamola, Dolors
    Companys-Alemany, Julia
    Corpas, Ruben
    Sanfeliu, Coral
    Perez, Belen
    Isabel Loza, M.
    Brea, Jose
    Morisseau, Christophe
    Hammock, Bruce D.
    Vazquez, Santiago
    Pallas, Merce
    Galdeano, Carles
    NEUROTHERAPEUTICS, 2020, 17 (04) : 1825 - 1835